These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 8650939)
1. [Therapy of hyperlipidemia]. Keller C Wien Med Wochenschr; 1994; 144(12-13):330-2. PubMed ID: 8650939 [TBL] [Abstract][Full Text] [Related]
2. [44. Normalizing blood lipids--with diet, sports and antilipemic agents]. Faust M; Krone W MMW Fortschr Med; 2003 May; 145(19):I-X; quiz XI-XII. PubMed ID: 12813992 [No Abstract] [Full Text] [Related]
3. [Effects of lipid lowering measures on coronary perfusion]. Steinmetz A; Maisch B; Noll B Z Kardiol; 1997; 86 Suppl 1():43-55. PubMed ID: 9173721 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of lipid metabolism disorders in the elderly]. Mizera W; Grzeszczak W Wiad Lek; 1998; 51 Suppl 2():52-7. PubMed ID: 9686534 [TBL] [Abstract][Full Text] [Related]
5. [Radical therapy of refractory hyperlipidemia: extracorporeal cholesterol elimination]. Kostner KM Wien Med Wochenschr; 1994; 144(12-13):333-5. PubMed ID: 8650940 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of hyperlipidemia in the prevention of ischemic heart disease. A proposal for the unification of medical management. I and II]. Adamska-Dyniewska H; Chojnowska-Jezierska J; Cybulska B; Dzieniszewski J; Hryniewiecki L; Idzior-Waluś B; Jabłońska-Kaszewska I; Jaszcz-Kanecka A; Kłosiewicz-Latoszek L; Kokot F Wiad Lek; 1992 May; 45(9-10):388-400. PubMed ID: 1441551 [No Abstract] [Full Text] [Related]
7. Management of dyslipidemia in adults. Ahmed SM; Clasen ME; Donnelly JE Am Fam Physician; 1998 May; 57(9):2192-2204, 2207-8. PubMed ID: 9606309 [TBL] [Abstract][Full Text] [Related]
8. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial. Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476 [TBL] [Abstract][Full Text] [Related]
10. Hyperlipidemia management in patients with cardiovascular and cerebrovascular disease. J Fla Med Assoc; 1998 Apr; 85(1):26-8. PubMed ID: 9782725 [No Abstract] [Full Text] [Related]
11. [Hyperlipidemia: therapeutic principles in clinical practice]. Müller-Wieland D; Krone W Med Klin (Munich); 2003 Dec; 98(12):739-43. PubMed ID: 14685674 [TBL] [Abstract][Full Text] [Related]
12. Management of hyperlipidaemia. Sum CF; Tan CE; Chew LS Singapore Med J; 1995 Aug; 36(4):410-6. PubMed ID: 8919159 [TBL] [Abstract][Full Text] [Related]
13. The use of lipid-lowering agents in HIV-infected patients. Meienberg F; Battegay E; Bucher HC; Battegay M J HIV Ther; 2001 May; 6(2):40-4. PubMed ID: 11501203 [No Abstract] [Full Text] [Related]
14. Lipid lowering therapy and military aviators. Khan MA; Amroliwalla FK Aviat Space Environ Med; 1996 Sep; 67(9):867-71. PubMed ID: 9025804 [TBL] [Abstract][Full Text] [Related]
15. [The management of familial hyperlipidemia diagnosed in childhood]. de Gennes JL; Loison J Ann Pediatr (Paris); 1989 Nov; 36(9):611-4. PubMed ID: 2589777 [No Abstract] [Full Text] [Related]
16. [Hyperlipoproteinemias in childhood]. Widhalm K Wien Med Wochenschr; 1994; 144(12-13):320-3. PubMed ID: 8650937 [TBL] [Abstract][Full Text] [Related]
17. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus. Udawat H; Goyal RK Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472 [TBL] [Abstract][Full Text] [Related]
18. A Baedeker for fat-controlled diets. II. Types of hyperlipidemia and their response to diet. Brown HB; Farrand M Ohio State Med J; 1967 Mar; 63(3):341-2. PubMed ID: 6040193 [No Abstract] [Full Text] [Related]
19. Evidence for gene-environmental interactions in Utah families with hypertension, dyslipidaemia and early coronary heart disease. Williams RR; Hunt SC; Hopkins PN; Wu LL; Schumacher MC; Stults BM; Ball L; Ware J; Hasstedt SJ; Lalouel JM Clin Exp Pharmacol Physiol Suppl; 1992; 20():1-6. PubMed ID: 1446402 [TBL] [Abstract][Full Text] [Related]
20. [Blood lipid derangement common in peripheral artery disease. Lipid-lowering agents may alleviate symptoms and slow the atherosclerotic process]. Bröijersén A; Wiklund B; Angelin B Lakartidningen; 2001 Sep; 98(36):3788-93. PubMed ID: 11586809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]